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The Ia antigenic specificities have been detected predominantly on the surface 
of B cells and are coded for by genes within the H-2 complex in the mouse (1, 2). 
The current interest in this antigenic system centers around its close genetic, 
and possibly functional relationship to the Ir genes, also found within the same I 
region of the H-2 complex (1, 3). Accordingly,  we have been investigating some 
of the properties and the role of Ia antigenic specificities in immune responses. 
We have recently published data showing that (a) Ia antigens, of low molecular 
weight, are found in serum (4) and in other tissue fluids and secretions (5); (b) 
while these specificities are found predominantly  (but not exclusively)  on the 
surface of B cells they are in fact produced by T cells (6).  It is therefore of some 
importance  to  define  the  type  of T  cell  which  produces  these  specificities, 
especially in the light of recent data (7) which convincingly demonstrated that 
on the  basis  of Ly  antigens,  "helper"  and  "killer"  T  cells  consist  of different 
subpopulations of T lymphocytes. 
In this paper we describe experiments that demonstrate that the subpopula- 
tion  of splenocytes  which  secretes  Ia  antigens  is  nonadherent  and  has  the 
surface phenotype of 0 +, Ig-,  Ia-,  Ly-1 +, Ly-2-. 
Materials and Methods 
Mice.  The mice used in the experiments are listed in the tables. CBA/H mice were raised at 
the  Australian  National  University,  Canberra,  and  all  other  mice  at  the  Austin  Hospital, 
Melbourne.  These  mice  were  originally obtained  from  The Jackson  Laboratory,  Bar  Harbor, 
Maine. We are particularly grateful to Dr. Marianna Cherry of The Jackson Laboratory for the 
supply of C57BL/6-Ly-1 ~ and B6.PL(75NS) strains which are congenic at the Ly-1  and Ly-2 loci, 
respectively, with C57BL/6. 
Antisera.  The characteristics of the antisera used are summarized in Table I. The anti-Ly and 
anti-Thy-1  sera  were  produced  by  immunizing recipients with  six  weekly  injections of donor 
thymus cells, whereas in the case of the mouse anti-Ia serum, recipient mice received donor lymph 
node and spleen cells.  One cell donor was used for every 5-10 recipients, and after the initial 
immunization regime, mice were bled and immunized at weekly intervals. These mouse antisera 
were tested by a cytotoxicity test using rabbit complement (4). The anti-Ly sera were considered to 
be specific for Ly-l.1 and for Ly-2.1 as (a) they were raised in donor-recipient combinations which 
are congenic for the Ly-1  and Ly-2 loci, respectively; (b) they reacted with the appropriate strains 
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TABLE  I 
Alloantisera  Used  in the  Various Experiments 
Specificity  Donor  Recipient 
Titer (% kill)* 
Thymus  Spleen  Lymph node 
Ly-l.l:~ (AS 379)  C57BL/6-Ly-I  ~  (C57BI.J6  x A)F,  >1/512 (100%)  1/256 (40%)  1/512 (70%) 
Ly-2.1$ (AS 457)  B6.PL(75NS)  (B10.AKM  x 129)F,  > 1/512 (85%)  1/32 (30%)  1/54 (50%) 
1a-1,2,3,7* (AS 383)  A.TL  A.TH  0  I/2,500 (65%)  1/2,000 (30%) 
Thy-l.2  C3H  AKR  >1/1,000 (100%)  1/16 (30%)  1/32 (65%) 
* %  kill: the maximum percent  lysis  of cells in the particular tissue using  a cytotoxic  test and rabbit complement. 
$ Raised in strains congenic  at the various loci and considered  therefore  to be functionally  specific. 
(8)  in  accordance with  their assigned specificities; and  (c)  autoantibodies were  removed by 
extensively absorbing both sera with C57BL/6 thymus cells. 
Fractionation  of Spleen  Cell Populations 
DEPLETION AND ENRICHMENT OF  Ig  + CELLS.  Cells bearing surface Ig were removed from a 
suspension of CBA/H  spleen cells by  forming Ig  rosettes and  separating the  rosetting and 
nonrosetting cells by centrifugation on Isopaque/Ficoll (9).  Briefly, sheep red cells (SRC) were 
coated, via CrCI3, with sheep anti-rabbit IgG and were mixed with CBA/H spleen cells which had 
been reacted with rabbit anti-mouse Ig. The mixture of SRC and spleen cells was centrifuged at 
400 g,  the cells suspended in their own supernate, and the rosette-forming cells subsequently 
sedimented using Isopaque/Ficoll as previously described (9). The Ig- cells were harvested from 
the Isopaque/Ficoll medium interface, and Ig  ÷ cells were recovered from the red cell pellet. 
DEPLETION OF  CELLS  BEARING Thy-l.2,  Ly-l.1,  Ly-2.1, OR  Ia SURFACE ANTIGENS. Spleen  cells 
were treated with the different antisera for 30  min at 37°C,  10 ml of medium added, the cells 
sedimented, complement added, and a further 30-min period of  incubation at 37°C performed, after 
which the cells were washed twice in medium (10% fetal calf serum (FCS) in phosphate-buffered 
saline) and their viability assessed. The amount of  antiserum used was always adequate to lyse all 
cells of that particular specificity, the  amounts being calculated,  by  extrapolation, from the 
cytotoxicity titer curves. To check this, retreatment of the cells with additional antiserum and 
complement was performed, and this did not lead to additional cell lysis. The antiserum treat- 
ments were as follows: (a) Anti-Thy-l.2:2 ×  108 spleen cells in 1.6 ml were mixed with 0.4 ml of 
anti-Thy-l.2 (i.e., final dilution 1/5), incubated, and after washing 2 ml of guinea pig complement 
(GPC) was added at a dilution of 1/3. This complement was absorbed with agarose immediately 
before use.  (b) Anti-Ly-l.1, anti-Ly-2.1, and  anti-Ia-1,  2,  3,  7:  cells were suspended in  1.0-ml 
aliquots containing 1.5  ×  l0  s cells and exposed to 1.0 ml of the different antisera at 1/2 dilution. 
After incubation and washing, they were then treated with 1.3  ml of rabbit complement (RC) 
(dilution 1/3). After these treatments, the percentage of  cells lysed was anti-Thy-l.2, 34%; anti-Ly- 
1.1, 42%; anti-Ly-2.1, 21%; anti-Ia, 58%; RC, 12%; and GPC, 8%. After treatment with antiserum, 
dead cells were removed by centrifugation on Isopaque/Ficoll (10). 
DEPLETmN OF MACROPHAGES.  Macrophages were removed from the CBA/H spleen cell popula- 
tions by first incubating the cells with carbonyl iron and then removing the phagocytic cells with a 
magnet as previously described (11). 
Tissue Culture Conditions.  The conditions of tissue culture have been previously described in 
detail (6). Briefly, the various spleen cell populations from CBA/H mice were cultured in Petri 
dishes in 10 ml ofF15 medium (Grand Island Biological Co., Grand Island, New York) lacking FCS 
for 5 h at 37°C in 10% CO2, 7% 02. After incubation, the supernates were collected, dialyzed against 
distilled water using acetylated dialysis tubing in  order to  retain  the  low  molecular weight 
material, and then freeze dried. The samples were reconstituted in 0.5 ml of  distilled water before 
testing. In some experiments either sodium azide (0.1%) was added to the culture fluids or the 
spleen cells were preincubated with 10  -5 M Pactamycin for 60 min at 37°C before being washed and 
cultured as above. The Pactamycin was kindly supplied by Dr. B. Loughman, Upjohn Company, 
Kalamazoo, Mich. McKENZIE  AND  PARISH  BRIEF  DEFINITIVE  REPORT  849 
TABLE  II 
Secretion of la Antigens  by Various Subpopulations of Spleen Cells 
In Vitro 
Spleen cell 
preparation 
cultured 
Cell no.$ 
Inhibition of anti-Ia sera* 
Mouse anti-Ia  Rabbit anti-la 
Unfractionated  2.0 ×  I0  s  160  640 
Macrophage depleted  1.8 x  I0  ~  160  640 
Ig  ÷ fraction  1.2 ×  10  M  0  40 
Ig  fraction  0.8 ×  10  M  160  400 
Anti-Thy-l.2 treated  1.3 ×  105  20  40 
GPC control  1.9  x  10  ~  80  320 
Anti-Ly-L1  treated  1.2  ×  10  ~  0  0 
Anti-Ly-2.1  treated  1.6 x 10  s  80  320 
Anti-Ia  k  treated  0.9 x  I0  ~  80  320 
RC control  1.8 x  10"  80  320 
Sodium azide treated  2,0 x  10  ~  20  40 
Pactamycin  treated  2.0  x  10  ~  20  80 
* Results expressed as reciprocal of dilution which gave 50% inhibition of cytotoxicity  (mouse anti-Ia) or 
rosetting  (rabbit anti-Ia). 
Cell numbers  cultured  after treatment  of 2.0  ×  10  ~ spleen cells by the various procedures. 
Measurement of Ia Content  in Tissue Culture Supernates.  The Ia content of the tissue culture 
supernates was measured by two inhibition techniques we have described in detail in our earlier 
papers (4, 5). The first assay measured the ability of serial dilutions of the sample to neutralize the 
cytotoxicity of the A.TH anti-A.TL serum. The second assay assessed the capacity of samples to 
inhibit the binding of rabbit anti-Ia antibodies to lymphocytes, the rabbit antibodies bound being 
detected by a rosetting procedure. 
Results 
Nature of the Cell-Secreting Ia Antigens.  The experimental approach was to 
measure the ability of subpopulations of spleen cells to secrete Ia antigens in 
vitro. The results are presented in Table II and confirm our earlier in vitro and 
in vivo findings that T  cells,  and not B  cells,  secrete  Ia antigens  (6). Thus, 
unfractionated spleen cells or those depleted of  macrophages or Ig  + cells secreted 
similar amounts of Ia antigen (both cytotoxicity and rosetting assays for Ia gave 
comparable results). However, when T cells were removed (anti-Thy-l.2 treat- 
ment) or when Ig  + cells were cultured, virtually no Ia material was detected, 
i.e., the secretory cell is Thy-l.2  +, Ig-, and is not a macrophage. Furthermore, 
this secretory T cell, although actively secreting Ia antigenic material, does not 
carry Ia on its cell surface, at least not in sufficient amounts to be detected with 
anti-Ia  k serum and complement, as treatment of spleen cells with anti-Ia antise- 
rum and RC had no greater effect on the secretion of Ia antigens than comple- 
ment alone. When the spleen cells were treated with the different Ly antisera 
and complement the results were clearly different. Anti-Ly-l.1 treatment com- 
pletely eliminated Ia  antigen  secretion,  whereas  anti-Ly-2.1 treatment was 
virtually without effect. Thus, the T-cell-secreting Ia is Ly-l.1  +, Ly-2.1-, and 
carries little or no Ia antigen on its surface. Furthermore, for Ia secretion to 
occur  an  active  cellular  metabolism  is  required  as  both  sodium  azide  and 
Pactamycin inhibited Ia secretion (Table II). 
Finally, it should be emphasized that the anti-Ly and anti-Ia sera used in 
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tional subpopulations ofT lymphocytes (12). For example, the anti-Ly-l.1 serum 
and complement kills helper and DTH T cells, whereas the anti-Ly-2.1 reagent 
removes cytotoxic T cells and T cells which suppress antibody responses (12). 
Discussion 
The data presented in this paper demonstrate that the cell type which secretes 
Ia antigens in vitro is a  nonadherent  T lymphocyte which is Ly-1  +, Ly-2-, and 
Ia-. Furthermore,  the release of Ia antigens by this subpopulation of T cells is a 
metabolically active process as secretion is inhibited by sodium azide, an uncou- 
pler of oxidative phosphorylation,  and by Pactamycin,  an inhibitor of protein 
synthesis (13). 
Recently it has been reported that helper T cells are Ly 1+2 -  (7, 12), whereas 
cytotoxic T  cells (7,  12) and T  cells which suppress antibody responses are Ly 
1-2  + (12,  14).  Thus on the basis of their cell surface phenotype, the cells that 
secrete Ia antigens  cannot be suppressor or cytotoxic T  cells and may well be 
helper T cells. Consistent with the helper T-cell origin of the Ia antigens is the 
observation  that  antigen-activated  T  cells  release  both  nonspecific  (15)  and 
antigen-specific  (16)  helper  factors  which  carry  Ia  antigens.  We  cannot  be 
completely certain, however, that helper cells are the secretors of Ia antigen, as 
it appears that the T  cells which mediate delayed-type hypersensitivity reac- 
tions are also Ly 1+2 -  and Ia- (12). 
The Ia antigen  which is secreted by T  lymphocytes appears to be predomi- 
nantly  of a  low molecular  weight  both  in  vivo  (4,  5)  and  in  vitro  (Jackson, 
Parish,  and  McKenzie,  in  preparation)  and  is  oligosaccharide  in  nature  (5). 
Inasmuch as the T-cell-replacing factors which carry Ia antigens are glycopro- 
teins of a  much higher  molecular weight  (15,  16),  it seems likely that  the Ia 
oligosaccharides may have arisen by proteolytic cleavage of these glycoprotein 
precursors. 
It is of interest that the T cells which secrete Ia antigens are not eliminated by 
treatment with anti-Ia serum and complement. The simplest interpretation  of 
this observation is that the Ia-secreting cells have little or no Ia antigen on their 
surface. Such an interpretation  is reminiscent of the old finding that antibody- 
forming cells have a very low density of antibody on their surface (17,  18). 
Summary 
It  was  found  that  Ia  antigens  are  rapidly  secreted  by a  subpopulation  of 
splenic T  lymphocytes which are  nonadherent  and  which express the surface 
phenotype Ly-1  +, Ly-2-, and Ia-.  Secretion of the Ia antigens  was a  metabol- 
ically active process which was inhibited by sodium azide and by Pactamycin, an 
inhibitor of protein synthesis. 
Received for publication 22 June 1976. 
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